0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Strengths available for Evolocumab autoinjectors:

Evolocumab autoinjectors 140mg/mL

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Evolocumab:

  • Albania
  • Algeria
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Bahrain
  • Belarus
  • Colombia
  • Cook Islands
  • Cuba
  • Estonia
  • Fiji
  • Gibraltar
  • Greenland
  • Guatemala
  • Hong Kong
  • India
  • Iraq
  • Kuwait
  • Latvia
  • Liechtenstein
  • Lithuania
  • Malta
  • Mauritius
  • Moldova, Republic of
  • Monaco
  • Morocco
  • Netherlands
  • New Zealand
  • Panama
  • Paraguay
  • Romania
  • Serbia
  • Spain
  • Switzerland
  • Tonga
  • United Kingdom, UK
  • United States, US
  • Uruguay
View All Countries

Latest news releases on Evolocumab:

Evolocumab - Wikipedia

Evolocumab (trade name Repatha) is a monoclonal antibody designed for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits ...

Efficacy and Safety of Evolocumab in Reducing Lipids and ...

Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL ...

Nutzenbewertungsverfahren zum Wirkstoff Evolocumab ...

Anwendungsgebiet gemäß Fachinformation für Evolocumab (Repatha® ) Hypercholesterinämie und gemischte Dyslipidämie: Repatha wird bei Erwachsenen mit primärer ...

Evolocumab and Clinical Outcomes in Patients with ...

Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels ...

Reduce Risk of MI & Stroke in CVD Patients | Repatha ...

Learn about PCSK9 inhibitor Repatha® (evolocumab) and how it reduces risk of stroke and myocardial infarction in your patients with established CV disease

Open Label Study to Evaluate Safety, Tolerability and ...

To describe the safety and tolerability of 80 weeks of subcutaneous (SC) evolocumab (AMG 145) when added to standard of care in pediatric subjects 10 to 17 years of ...

Evolocumab – NICE guidelines – Zoë Harcombe

2) Until recently (Ref 2), Evolocumab had been approved on the basis that it lowered cholesterol levels. There was no evidence that it had an impact on cardiovascular ...

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes ...

To compare the effect of alirocumab with placebo on the occurrence of cardiovascular events (composite endpoint of coronary heart disease (CHD) death, non-fatal ...

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in ...

Objectives. This study sought to evaluate the efficacy and safety of subcutaneous evolocumab compared with oral ezetimibe in hypercholesterolemic patients who are ...

High Cholesterol Treatment | Lower LDL | Repatha ...

Repatha® (evolocumab) is used to reduce the risk of heart attack or stroke in adults with heart disease or as a treatment to lower high LDL cholesterol, with diet ...

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK